1-4 of 4
Carolyn M. Mulroney
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective Randomized Clinical Trial Comparing a Calcineurin-Free Gvhd Prophylaxis Regimen with Post-Transplant Cyclophosphamide and Abatacept to Methotrexate and Tacrolimus

Divya Koura, James Mirocha, Kaitlyn C Dykes, Ayad Hamdan, Aaron Goodman, Tiffany N Tanaka, Carolyn M. Mulroney, Caitlin L. Costello, James K. Mangan, Edward D. Ball, Ah-Reum Jeong, Joseph Maroge, Michelle Padilla, Dimitrios Tzachanis
Journal: Blood
Blood (2023) 142 (Supplement 1): 3551.
https://doi.org/10.1182/blood-2023-173906
Published: 2023
Journal Articles

Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone (DIPD) As Salvage Therapy in Early Relapsed/Refractory Multiple Myeloma

Anupama Kumar, Aaron S. Rosenberg, Edward D. Ball, Sarah M. Larson, Lindsey Sirianni, Carolyn M. Mulroney, Caitlin L. Costello
Journal: Blood
Blood (2023) 142 (Supplement 1): 4750.
https://doi.org/10.1182/blood-2023-181091
Published: 2023
Journal Articles

A Phase I Trial of TGR-1202, a Next Generation Once-Daily PI3Kδ Inhibitor, in Combination with Brentuximab Vedotin, in Patients with Relapsed/Refractory Hodgkins Lymphoma

Radhakrishnan Ramchandren, MD, Carolyn M. Mulroney, MD, Manish R. Patel, MD, Peter Sportelli, Hari P. Miskin, MS, Robert W Chen, MD
Journal: Blood
Blood (2016) 128 (22): 4146.
https://doi.org/10.1182/blood.V128.22.4146.4146
Published: 2016
Journal Articles

Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies

Aaron M Goodman, MD, Michael Y. Choi, MD, Matthew J. Wieduwilt, MD PhD, Carolyn M. Mulroney, MD, Caitlin L Costello, MD, Razelle Kurzrock
Journal: Blood
Blood (2016) 128 (22): 5291.
https://doi.org/10.1182/blood.V128.22.5291.5291
Published: 2016